ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

American Journal of Transplantation

American Journal of Transplantation

Volume 1 Issue 1, Pages 93 - 95

Published Online: 17 Sep 2008

© 2010 American Society of Transplantation and the American Society of Transplant Surgeons



< Previous Abstract

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 52K)  | Related Articles | Citation Tracking

Fatal Disseminated Aspergillosis following Sequential Heart and Stem Cell Transplantation for Systemic Amyloidosis
Raymund R. Razonable a , Robin Patel a,b, *, Mark P. Wilhelm a , Morie A. Gertz c , Mark R. Litzow c , David J. Inwards c , Joseph A. Dearani d , Brooks S. Edwards e and Christopher G. McGregor d
Divisions of  a Infectious Diseases,  b Clinical Microbiology,  c Hematology,  d Transplantation Surgery, and  e Cardiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
* Corresponding author: Robin Patel, patel.robin@mayo.edu
Copyright Munksgaard International Publishers Ltd, 2001
KEYWORDS
Amyloidosis • aspergillosis • heart transplant • stem cell transplant

ABSTRACT

Infectious complications are a major cause of morbidity and mortality in transplant recipients. We describe a case of fatal disseminated aspergillosis immediately following autologous peripheral stem cell reconstitution in a patient who had undergone orthotopic heart transplantation for systemic amyloidosis. The case described suggests that the infectious risks in patients undergoing these sequential procedures may be distinct from those occurring in patients undergoing either procedure independently. Potential prophylactic and therapeutic interventions are discussed. Since this experimental and evolving approach for the management of systemic amyloidosis is potentially applicable to a limited number of patients, multicenter collaboration may be needed to further define the infectious risks in this unique subset of transplant recipients.


Received 18 October 2000, revised and accepted for publication 20 December 2000

DIGITAL OBJECT IDENTIFIER (DOI)
10.1034/j.1600-6143.2001.010117.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Latest News & Information
AJT Impact Factor

AJT Report
ATC
Sign Up Now
Sign Up Now
Sign Up Now

Sign Up Now

Be the first to know about new research in your field

Sign up for FREE e-alerts from Wiley-Blackwell journals!

Sign Up Now